| | | | | Präparat | Packungsgrösse | EFP | PP | SB | TK | Zusammensetzung | Zulassungsinhaber | Kat. | | | | |
---|
Was ist ein ATC-Code? | Zur ATC-Übersicht |
|
| | FI | | | Enrylaze 10 mg/vial | 3 | PA | PA | k.A. | | Injektionslösung: Crisantaspasum 10mg / 0.5ml | MEDA Pharmaceuticals Switzerland GmbH | A | FB | | G |  |
|
| | FI | PI | | Hydroxycarbamid Devatis 500 mg | 100 | PA | PA | k.A. | | Kapseln: Hydroxycarbamidum 500 mg | Devatis AG | A | FB | | G |  |
| | | | | Siklos 100 mg | 60 | PA | PA | k.A. | | comprimés filmés sécables: Hydroxycarbamidum 100 mg | iQone Healthcare Switzerland SA | A | FB | | G |  |
| | | | | Siklos 1000 mg | 30 | PA | PA | k.A. | | comprimés filmés sécables: Hydroxycarbamidum 1000 mg | iQone Healthcare Switzerland SA | A | FB | | G |  |
| | FI | PI | | Litalir | 100 Kapsel(n) | 65.38 | 87.15 | 10% | | Kapseln: Hydroxycarbamidum 500 mg | Cheplapharm Schweiz GmbH | ● A / SL / SO | FB | | G |  |
| | FI | PI | | Hydroxycarbamid Devatis 500 mg | 100 | 59.44 | 81.05 | 10% | | Kapseln: Hydroxycarbamidum 500 mg | Devatis AG | A / SL / SG | FB | | G |  |
| | FI | PI | | Hydroxycarbamid Labatec 500 mg | 50 | 29.72 | 48.75 | 10% | | Kapseln: Hydroxycarbamidum 500 mg | Labatec Pharma SA | A / SL / SG | FB | | G |  |
| | FI | PI | | Hydroxycarbamid Labatec 500 mg | 100 | 59.44 | 81.05 | 10% | | Kapseln: Hydroxycarbamidum 500 mg | Labatec Pharma SA | A / SL / SG | FB | | G |  |
| | FI | PI | | Hydroxycarbamid Labatec 500 mg | 30 | PA | PA | k.A. | | Kapseln: Hydroxycarbamidum 500 mg | Labatec Pharma SA | A | FB | | G |  |
|
L | | FI | | | Hycamtin 1 mg | Durchstechflasche(n) | 75.72 | 98.30 | 10% | | Lyophilisat: Topotecanum 1 mg | Sandoz Pharmaceuticals AG | A / SL / SO | FB | | G |  |
L | | FI | | | Hycamtin 4 mg | Durchstechflasche(n) | 269.88 | 308.25 | 10% | | Lyophilisat: Topotecanum 4 mg | Sandoz Pharmaceuticals AG | A / SL / SO | FB | | G |  |
L | | FI | | | Hycamtin 4 mg | 5 Durchstechflasche(n) | 1343.74 | 1469.55 | 10% | | Lyophilisat: Topotecanum 4 mg | Sandoz Pharmaceuticals AG | A / SL / SO | FB | | G |  |
L | | FI | PI | | Hycamtin 0.25 mg | 10 Kapsel(n) | 137.40 | 165.85 | 10% | | Kapseln: Topotecanum | Sandoz Pharmaceuticals AG | A / SL | FB | | G |  |
L | | FI | PI | | Hycamtin 1 mg | 10 Kapsel(n) | 549.59 | 614.15 | 10% | | Kapseln: Topotecanum 1 mg | Sandoz Pharmaceuticals AG | A / SL | FB | | G |  |
|
| | FI | | | Irinotecan Labatec 40 mg/2 ml | Durchstechflasche(n) | 37.89 | 57.60 | 10% | | Infusionskonzentrat: Irinotecani Hydrochloridum Trihydricum 40 mg | Labatec Pharma SA | A / SL / SG | FB | | G |  |
| | FI | | | Irinotecan Labatec 100 mg/5 ml | Durchstechflasche(n) | 91.81 | 116.25 | 10% | | Infusionskonzentrat: Irinotecani Hydrochloridum Trihydricum 100 mg | Labatec Pharma SA | A / SL / SG | FB | | G |  |
| | FI | | | Irinotecan Labatec 300 mg/15 ml | Durchstechflasche(n) | 245.64 | 283.55 | 10% | | Infusionskonzentrat: Irinotecani Hydrochloridum Trihydricum 300 mg | Labatec Pharma SA | A / SL / SG | FB | | G |  |
| | FI | | | Irinotecan Labatec 500 mg/25 ml | Durchstechflasche(n) | PA | PA | k.A. | | Infusionskonzentrat: Irinotecani Hydrochloridum Trihydricum 500 mg | Labatec Pharma SA | A | FB | | G |  |
| | FI | | | Irinotecan Orion 40 mg/2 ml | Durchstechflasche(n) | 44.51 | 67.45 | k.A. | | | Orion Pharma AG | A | FB | | G |  |
| | FI | | | Irinotecan Orion 100 mg/5 ml | Durchstechflasche(n) | 107.87 | 140.25 | k.A. | | | Orion Pharma AG | A | FB | | G |  |
| | FI | | | Irinotecan Orion 300 mg/15 ml | Durchstechflasche(n) | PA | PA | k.A. | | | Orion Pharma AG | A | FB | | G |  |
| | FI | | | Irinotecan Orion 500 mg/25 ml | Durchstechflasche(n) | PA | PA | k.A. | | | Orion Pharma AG | A | FB | | G |  |
| | FI | | | Irinotecan Sandoz 40 mg/2 ml | Durchstechflasche(n) | 45.07 | 68.15 | k.A. | | Infusionskonzentrat: Irinotecani Hydrochloridum Trihydricum 40mg / 2ml | Sandoz Pharmaceuticals AG | A | FB | | G |  |
| | FI | | | Irinotecan Sandoz 100 mg/5 ml | Durchstechflasche(n) | 109.22 | 141.80 | k.A. | | Infusionskonzentrat: Irinotecani Hydrochloridum Trihydricum 100mg / 5ml | Sandoz Pharmaceuticals AG | A | FB | | G |  |
| | FI | | | Irinotecan Sandoz 150 mg/7.5 ml | Durchstechflasche(n) | 158.91 | 198.85 | k.A. | | Infusionskonzentrat: Irinotecani Hydrochloridum Trihydricum 150mg / 7.5ml | Sandoz Pharmaceuticals AG | A | FB | | G |  |
| | FI | | | Irinotecan Sandoz 300 mg/15 ml | Durchstechflasche(n) | 294.88 | 354.90 | k.A. | | Infusionskonzentrat: Irinotecani Hydrochloridum Trihydricum 300mg / 15ml | Sandoz Pharmaceuticals AG | A | FB | | G |  |
| | FI | | | Irinotecan Sandoz 500 mg/25 ml | Durchstechflasche(n) | PA | PA | k.A. | | Infusionskonzentrat: Irinotecani Hydrochloridum Trihydricum 500mg / 25ml | Sandoz Pharmaceuticals AG | A | FB | | G |  |
|
| | FI | PI | | Lysodren | 100 Tablette(n) | PA | PA | k.A. | | Tabletten: Mitotanum 500 mg | EffRx Pharmaceuticals SA | A | FB | | G |  |
|
L | | FI | | | Oncaspar 750 UI/ml | | 1662.17 | 1824.15 | 10% | | Trockensubstanz: Pegaspargasum 3750 UI | Servier (Suisse) SA | A / SL | FB | | G |  |
|
L | | FI | | | Trisenox 12 mg/6 ml | 10 | 3416.68 | 3732.25 | 10% | | Infusionskonzentrat: Arsenii Trioxidum 12mg / 6ml | Teva Pharma AG | A / SL | FB | | G |  |
|
| | FI | PI | | Thromboreductin 0.5 mg | 42 Kapsel(n) | 94.59 | 119.70 | 10% | | Kapseln: Anagrelidum | OrPha Swiss GmbH | B / SL / SO | FB | | G |  |
| | FI | PI | | Thromboreductin 0.5 mg | 100 Kapsel(n) | 198.18 | 230.75 | 10% | | Kapseln: Anagrelidum | OrPha Swiss GmbH | B / SL / SO | FB | | G |  |
| | FI | PI | | Thromboreductin 1 mg | 100 Kapsel(n) | 325.02 | 367.90 | 10% | | Kapseln: Anagrelidum 1 mg | OrPha Swiss GmbH | B / SL / SO | FB | | G |  |
| | FI | PI | | Xagrid 0,5 mg | 100 Kapsel(n) | 207.67 | 240.45 | 10% | | Kapseln: Anagrelidum | Takeda Pharma AG | B / SL | FB | | G |  |
|
L | | FI | | | Halaven | Durchstechflasche(n) | 188.66 | 221.60 | 10% | | Injektionslösung: Eribulini Mesilas 1 mg | Eisai Pharma AG | A / SL | FB | | G |  |
|
L | | FI | | | Zaltrap 100 mg/4 ml | Durchstechflasche(n) | 388.94 | 439.40 | 10% | | concentré pour solution pour perfusion: Afliberceptum 100mg / 4ml | Sanofi-Aventis (Suisse) SA | A / SL | FB | | G |  |
L | | FI | | | Zaltrap 200 mg/8 ml | Durchstechflasche(n) | 777.87 | 862.40 | 10% | | concentré pour solution pour perfusion: Afliberceptum 200mg / 8ml | Sanofi-Aventis (Suisse) SA | A / SL | FB | | G |  |
|
L | | FI | PI | | Imlygic 10e8 | Durchstechflasche(n) à 1 ml | 2038.89 | 2233.85 | 10% | | Injektionslösung: Talimogenum Laherparepvecum 100 | Amgen Switzerland AG | A / SL | FB | | G |  |
|
L | | FI | PI | PS | Venclyxto 10 mg | 14 | 72.05 | 94.75 | 10% | | Filmtabletten: Venetoclaxum 10 mg | AbbVie AG | A / SL | FB | | G |  |
L | | FI | PI | PS | Venclyxto 50 mg | 7 | 180.11 | 212.30 | 10% | | Filmtabletten: Venetoclaxum 50 mg | AbbVie AG | A / SL | FB | | G |  |
L | | FI | PI | PS | Venclyxto 100 mg | 7 | 360.23 | 408.20 | 10% | | Filmtabletten: Venetoclaxum 100 mg | AbbVie AG | A / SL | FB | | G |  |
L | | FI | PI | PS | Venclyxto 100 mg | 14 | 720.46 | 799.95 | 10% | | Filmtabletten: Venetoclaxum 100 mg | AbbVie AG | A / SL | FB | | G |  |
L | | FI | PI | PS | Venclyxto 100 mg | 112 | 5763.66 | 6221.30 | 10% | | Filmtabletten: Venetoclaxum 100 mg | AbbVie AG | A / SL | FB | | G |  |
| | FI | PI | PS | Venclyxto 10 mg | 10 | PA | PA | k.A. | | Filmtabletten: Venetoclaxum 10 mg | AbbVie AG | A | FB | | G |  |
| | FI | | PS | Venclyxto 50 mg | 5 | PA | PA | k.A. | | Filmtabletten: Venetoclaxum 50 mg | AbbVie AG | A | FB | | G |  |
|
| | FI | PI | | Tibsovo 250 mg | 60 | PA | PA | k.A. | | Filmtabletten: Ivosidenibum 250 mg | Servier (Suisse) SA | A | FB | | G |  |
|
| | FI | PI | | Nexpovio 20 mg | 8 | PA | PA | k.A. | | Filmtabletten: Selinexorum 20 mg | Stemline Therapeutics Switzerland GmbH | A | FB | | G |  |
| | FI | PI | | Nexpovio 20 mg | 12 | PA | PA | k.A. | | Filmtabletten: Selinexorum 20 mg | Stemline Therapeutics Switzerland GmbH | A | FB | | G |  |
| | FI | PI | | Nexpovio 20 mg | 16 | PA | PA | k.A. | | Filmtabletten: Selinexorum 20 mg | Stemline Therapeutics Switzerland GmbH | A | FB | | G |  |
| | FI | PI | | Nexpovio 20 mg | 20 | PA | PA | k.A. | | Filmtabletten: Selinexorum 20 mg | Stemline Therapeutics Switzerland GmbH | A | FB | | G |  |
| | FI | PI | | Nexpovio 20 mg | 32 | PA | PA | k.A. | | Filmtabletten: Selinexorum 20 mg | Stemline Therapeutics Switzerland GmbH | A | FB | | G |  |
|
L | | FI | | | Elzonris 1mg / ml | | 16243.50 | 16973.65 | 10% | | Infusionskonzentrat: Tagraxofuspum 1 mg/ml | Stemline Therapeutics Switzerland GmbH | A / SL | FB | | G |  |